Medical Foods Market: Global Industry Analysis and Forecast (2024-2030) by Route of Administration, Product, Application, Sales Channel, and Region

Medical Foods Market Overview:

Foods that are formulated to be consumed or administered under the supervision of a physician as the sole means of managing a disease or condition whose distinctive nutritional requirements have been established by medical evaluation are classified as medical foods. Medical foods include special infant formulas, formulations for metabolic disorders, oral rehydration products, and products for chronic diarrhoea, as well as formulas for individuals with diabetes, AIDS, kidney disease, or inborn errors of metabolism. The Medical Foods Market report is come up with the PESTLE analysis, PORTER's five force analysis and segment analysis on the basis of product, route of administration, application, sales channel and region.

Though market forecast through 2027 is based on real output, demand and supply of 2022, 2022 numbers are also estimated on real numbers published by key players as well all-important players across the world. Market forecasting till 2029 is done based on past data from 2016 to 2019 with the impact of global lock down on the medical foods market in 2021 and 2022.

To get more Insights: Request Free Sample Report

Medical Foods Market Dynamics:

The growing senior population, which suffers from a variety of chronic and neurogenic conditions such as dementia, stroke, multiple sclerosis, and swallowing difficulties, necessitates specialized nutritional treatment, which is expected to drive the medical foods market during the forecast period. According to the World Health Organization, the global population of people aged 60 and over is expected to double from 12 percent to 22 percent between 2015 and 2050. Besides, the use of medical foods is expected to be driven by an increased demand to consume specialized meals in order to control chronic conditions such as obesity, diabetes, and other nutritional ailments.

Medical foods are also expected to drive the medical foods market because they are intended for specific dietary control with distinct nutritional requirements to treat specific conditions. Manufacturers' increasing product launch activities, as well as continual product development advances, are expected to drive product demand. Besides, there is a growing demand for the production of new food for special medical uses in order to cure new hereditary metabolic illnesses and control their incurable condition.

The Medical Foods market is expected to rise faster as more people explore medicinal foods to manage and control diabetic neuropathy and diabetes. Diabetes is one of the most common chronic diseases, and its incidence is steadily increasing. According to WHO figures published in 2019, diabetes is directly responsible for nearly 1.5 million deaths, making it the ninth greatest cause of death. Diabetic neuropathy is primarily caused by a poor lifestyle and diet, and medical foods can help to treat and control these conditions. According to the International Diabetic Federation, around 463 million adults have diabetes in 2019, with this figure expected to climb to 700 million by 2045.

Several industry consolidation initiatives by clinical nutrition manufacturers are also expected to drive market growth during the forecast period 2023-2029. Acquisitions, mergers, new launches, and partnerships by manufacturers to expand their product reach are expected to drive medical foods market growth in the forecast period. Nestle, for example, acquired Zenpen in January 2020 as part of an Asset Purchase Agreement to develop its clinical nutrition business.

Medical Foods Market Segment Analysis:

Based on the Route of Administration, the market is segmented into Oral, and Enteral. Oral route of administration segment is expected to hold the largest market share of xx% by 2029. The widespread use of the oral route for the administration of therapeutic meals is expected to drive the segment growth in the global market during the forecast period. A rise in production of oral products in the form of powders, tablets, and pre-thickened products is also expected to support segment adoption in the forecast period. Modulen, for example, is a Nestle medical food product that aids in the restoration of nutritional requirements in Crohn's disease patients. These are the factors that are expected to drives the growth of this segment in the Medical Foods market during the forecast period 2024-2030.

Based on the Product, the medical foods market is segmented into Pills, Powder, Liquid, and Others. Powder segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to the strong commercial availability of medical meals in powder form. In addition, the segment rise is being driven by the increasing demand and convenience of consumption among paediatric and geriatric patients suffering from various chronic conditions. Powder formulations, which may be supplied via enteral and oral routes to patients of all ages, are also highly recommended by physicians, and are expected to drive segment growth. Manufacturers are also concentrating on making medical foods that appeal to consumers.

Based on the Sales Channel, the market is segmented into Online Sales, Institutional Sales, and Retail Sales. Institutional Sales segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. In 2022, the institutional sales channel accounted for almost 40.0% of total revenue, which includes hospitals, home care settings, and handicap facilities. The segment is being driven by an increase in patient visits to hospitals and other healthcare institutions for the diagnosis and treatment of a variety of chronic and dietary illnesses. Doctors recommend medical meals for the treatment of specific diseases. Besides, the market is expected to be driven by patients' rising preference for consulting a doctor at a hospital for chronic disease care. Furthermore, the increasing number of private and governmental healthcare institutions, as well as the global chronic illness patient population, is expected to boost segment growth in the Medical Foods Market during the forecast period.

Medical Foods Market Regional Insights:

North America region is expected to dominate the Medical Foods market during the forecast period 2024-2030. North America region is expected to hold the largest market share of xx% by 2029. The market is being driven by the existence of global firms such as Abbott Laboratories and Mead Johnson & Company, as well as their significant revenue generation. A number of strategic initiatives by leading companies in the form of mergers, acquisitions, and product launches, as well as increasing chronic disease prevalence, as well as increased adoption of medical food products by healthcare professionals and patients in the North American region, are driving medical foods market growth. These are the key major drivers that are expected to drives the growth of the North America region in the market during the forecast period.

Asia Pacific region is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to the rising number of cancer and diabetic patients, as well as many government initiatives in the healthcare sector in the Asia Pacific region. Asia Pacific accounts for more than half of all new cancer cases worldwide each year, according to Janssen, a Johnson & Johnson Pte. Ltd. company. Besides, according to this analysis, cancer-related deaths are expected to rise by 36% in the Asia Pacific region by 2030, boosting the medical foods market's growth in this region during the forecast period.

The Asia Pacific medical foods market is expected to be driven by the region's growing population and increased awareness among patients with chronic conditions to eat medicinal food for better health management. Furthermore, the presence of significant companies on the ground and the region's unexplored prospects are two major drivers of regional market growth.

The objective of the report is to present a comprehensive analysis of the Medical Foods Market to the stakeholders in the industry. The report provides trends that are most dominant in the Medical Foods Market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

The qualitative and quantitative data provided in the Medical Foods Market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Medical Foods Market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the market.

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the Medical Foods Market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the Market. Economic variables aid in the analysis of economic performance drivers that have an impact on the Market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the Medical Foods Market is aided by legal factors.

Medical Foods Market Scope:

Medical Foods Market Key Players

• Nestle
• Danone
• Abbott
• Mead Johnson & Company, LLC
• Fresenius Kabi
• Targeted Medical Pharma, Inc.
• Primus Pharmaceuticals, Inc.
• Medtrition, Inc.
• Reckitt Benckiser Group plc.
• Metagenetics, Inc.
• Cerecin Inc.
• Alfasigma USA, Inc.
• Others